Plasmodium RNA

Plasmodium RNA encompasses the total pool of ribonucleic acids, including messenger RNA, ribosomal RNA, and transfer RNA, produced by malaria-causing parasites during their complex life cycle. These RNA molecules are indispensable for the parasite's protein synthesis, metabolic regulation, and stage-specific development within both the human host and the mosquito vector (Daily et al., 2007). Ribosomal RNA (rRNA), particularly within the parasite's apicoplast—a relict plastid—serves as a validated therapeutic target for several classes of antibiotics that inhibit translation (Dahl & Rosenthal, 2007). Beyond its role in parasite biology, Plasmodium RNA is a significant immunological trigger; it is recognized by host endosomal receptors like TLR7 and TLR8, which initiates the innate immune response characteristic of clinical malaria (Lau et al., 2015). Furthermore, the high copy number and stability of certain RNA species, such as the 18S rRNA, make them superior biomarkers for highly sensitive molecular diagnostics compared to DNA-based methods (Murphy et al., 2012). Understanding the dynamics of Plasmodium RNA is therefore crucial for developing both new antimalarial agents and improved diagnostic tools.

Other names

Malaria parasite RNAPlasmodium falciparum RNAPlasmodium ribosomal RNAParasite RNA PAMP

Inhibition of the parasite translation machinery by binding to ribosomal RNA (rRNA) subunits, particularly within the apicoplast (Dahl & Rosenthal, 2007); stimulation of host endosomal Toll-like receptors 7 and 8 (TLR7/8) to induce pro-inflammatory cytokine production (Lau et al., 2015).